Center for Vaccine Research
Wednesday, May 26, 2021
Promising early data suggest that this approach can provide a convenient and cost-effective therapeutic option to control the coronavirus pandemic.
Thursday, May 20, 2021
In the latest Pitt Perspective, see how the University is fighting COVID-19 by questioning conventional wisdom and finding new approaches to research, treatment and vaccine development.
Monday, April 12, 2021
On the 66th anniversary of the Salk polio vaccine being declared safe and effective, Pitt premieres a new film, “Chasing Covid,” that draws parallels between that event and Pitt’s current global collaboration on vaccine research.
Monday, March 15, 2021
CBS chief medical correspondent Jon LaPook traveled to Pitt’s Center for Vaccine Research to better understand coronavirus variants.
Thursday, February 4, 2021
A scientific detective story that unfolded in Pitt’s Center for Vaccine Research unearths how the virus that causes COVID-19 evolves new variants that evade antibodies. Director Paul Duprex says this evolution is why it’s important to develop multiple tools to fight the pandemic.
Thursday, December 17, 2020
With the delivery of the first batches of SARS-CoV-2 vaccines, providers and laypeople alike have questions about the technologies behind them. Pitt Med magazine enlisted Jeremy Berg, Pitt’s associate senior vice chancellor for science strategy and planning in the health sciences, to help explain.
Tuesday, November 17, 2020
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
Monday, November 9, 2020
Pitt Experts Optimistic About Vaccine Candidate’s Efficacy, Advise People Continue Protecting Themselves
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
Thursday, November 5, 2020
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.
Friday, October 16, 2020
If you missed yesterday’s panel discussion on rolling out a vaccine for COVID-19, watch the recording here, or read highlights from a wide-ranging discussion.